Business

ACW accesses up to $13.8m in non-dilutive R&D tax funding

ACW accesses up to $13.8m in non-dilutive R&D tax funding

Actinogen Medical LimitedJune 29, 20255
ACW accesses up to $13.8m in non-dilutive R&D tax funding

About this update from Actinogen Medical Limited

Actinogen Medical Ltd has released a press release. View Attachment

View stock analysis, news, and events for Actinogen Medical Limited

More from Actinogen Medical Limited

All Actinogen Medical Limited news →